- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy high growth potential
Canadian Pharmaceuticals & Biotech Healthy high growth potential
Results
2
0 new
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Medexus Pharmaceuticals
Market Cap: CA$132.4m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$4.04
7D
-1.7%
1Y
28.3%
Cardiol Therapeutics
Market Cap: CA$171.8m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.51
7D
0.7%
1Y
-24.9%